Ramy Abdelnaby: Exploring The Timing of Antiplatelet Administration In Minor Stroke Post-Thrombolysis
Ramy Abdelnaby, Consultant Neurologist / Oberarzt at RWTH Aachen University Hospital, shared on LinkedIn about a recent article by Hui-Sheng Chen et al, published in European Heart Journal:
”Exploring the timing of antiplatelet administration in minor stroke post-thrombolysis, the EAST trial offers a comprehensive insight.
Conducted across multiple centers in China, this double-blind, randomized study evaluated the efficacy and safety of early antiplatelet treatment within 6 hours of intravenous thrombolysis in patients with mild neurological deficits.
Despite the high expectations, the trial concluded there’s no significant difference in achieving excellent functional outcomes at 90 days between the early treatment group and placebo.
This challenges existing paradigms and emphasizes the need for cautious decision-making in early antiplatelet therapy.”
Title: Early antiplatelet treatment for minor stroke following thrombolysis: the EAST trial
Authors: Hui-Sheng Chen, Yu Cui, Xiao-Qiu Li, Xin-Hong Wang, Chang-Hao Jiang, Jing Li, Zhi-Mei Yuan, Li-Wei Zhao, Nan Kong, Hai-Ning Mi, Jiang Lu, Hong Zhang, You-Jun Liu, Er-Qiang Wang, Yan Yang, Cheng-Guang Song, Yi Zhang, Shu-Yao Wang, Hong-Guo Dai, Yi Yang, Shi-Mei Geng, Rong Yin, Duo-Lao Wang, Thanh N. Nguyen
Read the Full Article on European Heart Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 6, 2026, 19:25Ambreen Kashif: Highlighting the Impact of Temporary Donor Deferrals on Donor Retention
-
Jul 6, 2026, 19:23Rob Mac Sweeney: Anticoagulation Strategies for Cardiopulmonary Bypass in Heparin-Induced Thrombocytopenia
-
Jul 6, 2026, 19:22Nthabiseng Bapela: Interpreting INR in Patients on Warfarin – A Practical Clinical Framework
-
Jul 6, 2026, 19:20Hamza Mohamed: Key Highlights from the 2026 AHA/ACC Multisociety Guideline on Acute PE
-
Jul 6, 2026, 18:58Mostafa Faisal: High PNH Type II Neutrophil Proportions Are Associated With Thrombosis
-
Jul 6, 2026, 17:57When Hematocrit Exceeds 70 Percent: Challenges in Peripheral Blood Smear Evaluation and CBC Analysis – Seema Dawood
-
Jul 6, 2026, 17:382026 ACC/AHA Multisociety Dyslipidemia Guideline: Key Updates for Vascular Specialists – Batool Abuhalimeh
-
Jul 6, 2026, 17:27Nicolas Gendron: Should Carbon Footprint Influence Therapeutic Decisions?
-
Jul 6, 2026, 17:15Sanchit Sharma։ Continuous Anticoagulation in PVT with Varices